
jan pm et
summari global medic devic manufactur leadership posit pacemak defibril
orthoped diabet manag medic market
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan pm stock trade
look fy april sale account
divestitur medic suppli unit
declin billion billion fy
segment look largest unit
cardiac vascular sale grow
covidien declin restor
therapi grow diabet
group declin expect emerg
market sale grow high-singl digit
account sale
see fy gross margin
basi point bp oper margin
bp better leverag
juli sold medic suppli unit
billion januari
complet acquisit
covidien plc billion think
combin make strateg sens
compani product complementari
focus cardiovascular
orthoped covidien endomechan
instrument stapl sutur
minim invas surgeri move
corpor headquart ireland due
lower corpor tax rate vs
see fy ep
view sale medic suppli unit
initi part covidien
acquisit posit believ unit
slower growth potenti lower margin
think covidien acquisit expand
global reach diversifi product
line make market leader numer
market think signific presenc
emerg market particularli china latin
america like drive growth higher
emerg market account
sale collect fasting-grow
segment sale growth
low-to-mid teen also commit
invest increment billion
next decad believ share
trade forward ep
estim peer near
high end recent five-year rang
attract valu
risk opinion target price includ
loss share key market fda reject
key product weak
target price
forward ep estim line
risk assess reflect exposur intens
competit area medic equip market
typic character rel short
product life cycl price pressur threat
new market entrant howev believ off-set
mani competit advantag scale
oper sale forc product breadth
see financi strength
ep estim base cfra oper earn histor
earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview lead posit medic devic categori includ cardiac
rhythm manag spinal vascular neurolog cardiac surgeri compani acquir covidien plc
januari billion
compani oper follow segment cardiac vascular group minim invas
group restor therapi group diabet group
cardiac rhythm heart failur diseas manag divis develop manufactur market
product diagnosi treatment manag heart rhythm disord heart failur
compani product includ implant devic lead deliveri system product treatment
atrial fibril af product design reduc surgic site infect inform system
manag patient crhf devic integr health solut busi follow
princip product servic offer crhf divis
implant cardiac pacemak pacemak compani latest gener pacemak system
advisa revo mri surescan model receiv unit state food drug
administr fda approv advisa ensura mri surescan model well
micratranscathet pace receiv conformit europeen ce mark approv
implant cardiovert defibril compani latest gener evera mri
surescan first system ce mark approv full-bodi mri scan
implant cardiac resynchron therapi devic crt-d crt-p compani crt-d
viva/brava famili attain performa quadripolar lead featur new algorithm call
adaptivcrt improv heart failur patient respons rate crt-d therapi
minim invas therapi group formerli covidien consist surgic solut surgic
surgic solut develop manufactur market product therapi treat diseas
condit typic address surgeon addit compani develop manufactur
market product field minim invas gastrointestin diagnost ablat
intervent lung follow princip product offer surgic solut divis
surgic innov busi includ sale stapl vessel seal fixat hernia mechan
devic mesh hardwar surgic instrument sutur electrosurgeri product advanc
surgic product includ tri-stapl technolog platform endoscop stapl includ endo
gia reload reinforc reload tri-stapl technolog endo gia ultra univers stapler
idriv power stapl system ligasur vessel seal system multifunct laparoscop
instrument use forcetriad sonicis cordless ultrason dissect system absorbatack
absorb mesh fixat devic hernia repair symbotex composit mesh surgic laparoscop
open ventral hernia repair parietex progrip selfgrip biocompat solut inguin
restor therapi group includ spine neuromodul spine divis develop
manufactur market line medic devic implant use treatment spine
musculoskelet system compani product therapi treat variou condit affect
spine includ degen disc diseas spinal deform spinal tumor fractur spine
stenosi spine divis also provid biolog solut orthoped dental market
concert surgic technolog busi compani offer uniqu highli differenti
navig neuromonitor power technolog design spine procedur neuromodul
divis includ implant neurostimul target drug deliveri system manag
chronic pain common movement disord spastic urolog gastrointestin disord
neurostimul use implant medic devic similar pacemak call neurostimul
diabet group consist three divis intens insulin manag non-intens diabet
therapi diabet servic solut develop manufactur market advanc
integr diabet manag solut includ insulin pump therapi continu glucos
monitor cgm system therapi manag softwar
senior vice presid
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli under-valued
bullish sinc novemb technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
capit budget amid shift
procedur inpati outpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
sub-index increas vs rise
 composit index follow
rise health equip
index vs declin
composit index year date
juli health
equip index rose vs rise
 composit index
fundament outlook health care
equip sub-industri next month
neutral continu view mani product
categori histor recession-resist
expect continu grow albeit
slowli growth procedur rate
slow area normal view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped recent howev equip
maker think certain procedur rate may
stabil start recov
medic devic tax requir
healthcar reform law went effect
januari temporarili
suspend
elect donald trump republican
retain control congress believ
gop abil substanti alter
afford act includ potenti
elimin variou health care sector fee
tax although gop replac
remain uncertain believ
potenti fewer insur patient
neg impact equip sub-industri
fewer insur patient would like lead
fewer procedur anticip
hospit largest buyer
medic equip would also advers
impact could pressur
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
demand certain product categori
unfavor foreign exchang continu
hospit becom cautiou regard
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
becton dickinson compani
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
in-lin peer forward ep estim jan-q ep
vs ahead estim sale rose broad-bas
growth across geographi product line sale intern
emerg market cardiac vascular rose minim invas
therapi restor therapi diabet also encourag
continu margin improv synergi achiev integr
covidien acquisit oper margin expand /jeffrey loo cfa
et capit iq keep buy opinion share
medtron plc lower target
in-lin peer forward ep estim oct-q ep
vs estim lower fy apr ep
sale rose growth forecast partli slower
 sale growth diabet unit due time approv
shipment minim minim system although believ
issu may impact sale next quarter believ broad product
portfolio geograph reach continu drive consist sale growth
plc maintain target price fy
apr ep estim multipl slight premium peer reflect
averag revenu growth outlook trim fy ep estim
set fy estim report jul-q oper
ep vs capit iq consensu jul-q report
sale fell cardiac vascular sale minim invas
therapi restor therapi expect increas
sale fy driven growth emerg market jeffrey loo cfa /k
analyst research note compani news
plc announc robert white previous senior vice presid
presid medtron asia pacif apac region name
execut vice presid presid medtron minim
therapi group mitg addit compani announc chri
senior vice presid presid medtron greater china
region assum posit apac region presid remain
interim presid greater china region perman successor
name come week leadership chang effect immedi
leadership chang result bryan hanson departur becom
presid ceo anoth public medic technolog compani effect
decemb hanson former execut vice presid mitg bob
white join upon close covidien acquisit
presid apac region base singapor role
white respons commerci growth busi
region includ leadership four main product
therapi group region busi develop effort govern partner
develop strategi talent develop retent oper
compani enabl function white leadership
region grown revenu billion fiscal year
billion fiscal year white previou leadership posit
covidien includ serv presid respiratori monitor
busi presid emerg market prior time covidien
white held variou leadership posit chri
join bayer healthcar serv
presid greater china region base shanghai sinc time
medtron greater china region includ china hong kong taiwan
respons commerci oper region
talent develop retent serv princip liaison
chines govern prior join work bayer
healthcar led asia pacif region base singapor
greater china region base beij
et cfra keep buy opinion share plc
keep target in-lin peer
forward ep estim oct-q ep vs
view lower fy april fy ep estim
sale account divestitur fell
rose pro-forma basi sale driven robust sale emerg
market account sale sale broad-bas
note diabet sale limit sensor suppli constraint said
capac expans remain on-track /jeffrey loo cfa
et cfra keep buy opinion share plc
keep target in-lin peer fy
apr ep estim jul-q ep vs ahead
estim sale rose sale emerg market
account sale sale neg impact
vascular group sale rose minim invas therapi restor
therapi diabet group fell see rebound diabet amid
strong adopt cgm sensor /jeffrey loo cfa
rais target in-lin peer
fy apr ep estim set fy ep
apr-q ep vs ahead estim sale rose
emerg market sale sale growth broad-bas
vascular minim invas therapi restor therapi
diabet group encourag continu
growth look market share gain particularli emerg market
guid fy sale ep /jeffrey loo cfa
et capit iq keep buy opinion share
medtron plc rais target
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
